NUS scientists develop novel device suitable for electronics, robotics and healthcare applications

NewsGuard 100/100 Score

A team of scientists from the National University of Singapore (NUS) Faculty of Engineering has developed a wearable liquid-based microfluidic tactile sensor that is small, thin, highly flexible and durable. Simple and cost-effective to produce, this novel device is very suitable for applications such as soft robotics, wearable consumer electronics, smart medical prosthetic devices, as well as real-time healthcare monitoring.

Tactile sensors are data acquisition devices that detect and measure a diversity of properties arising from physical interaction and translate the information acquired to be analysed by an interconnected intelligent system. Conventional tactile sensors that are available today are typically rigid and in solid-state form, restricting various natural body movements when used and may also be subjected to plastic deformation and failure when pressure is exerted, resulting in compromises in conformability, durability and overall robustness.

Addressing the limitations of existing tactile sensors, a team of researchers led by Professor Lim Chwee Teck from NUS' Department of Biomedical Engineering achieves a significant technological breakthrough by adopting a liquid-based pressure sensing method in the design of such sensors.

Novel liquid-based pressure sensing element

The newly developed microfluidic tactile sensor is fabricated on a flexible substrate like silicone rubber, and uses non-corrosive, non-toxic 2D nanomaterial suspension in liquid form, such as graphene oxide, as the pressure sensing element to recognise force-induced changes.

The NUS team has put the device through rigorous tests and also subjected it to various strenuous deformations, such as pressing, bending or stretching, to validate the robustness and versatility of its invention. In fact, despite having placed the device under extreme abusive mechanical force, such as running a car tyre over it, the electrical output was highly uniformed and there was no damage to the functionality of the device.

From idea to market

The team's invention will further advance the applications of tactile sensors, which are already increasingly utilised for monitoring critical parameters in biomedical applications, especially for those that may come in contact with human skin or where human movement is highly versatile.

"This liquid-based microfluidic tactile sensor, which is the first of its kind, addresses an existing gap in the market. Being thin and flexible, the sensor gives a better fit when monitoring natural body movements. Its small size, durability and ease of production further differentiate this novel device from conventional tactile sensors. With the rapid advancement of healthcare and biomedical technologies as well as consumer electronics, we are optimistic about new possibilities to commercialise our invention," said Prof Lim.

The NUS team has already filed a patent for its creation and is also keen to explore licensing partnerships in commercial development. Earlier this year, it participated in InnovFest unBound, Asia's premier technology transfer event organised by NUS Enterprise aimed at showcasing Asian innovation to a global audience and taking technology out to the market.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI in healthcare shows promise in trials but needs real-world testing to ensure effectiveness